DERMABOND® PRINEO® Skin Closure System provides a flexible microbial barrier with 99% protection in vitro for 72 hours against organisms commonly responsible for SSIs.±1
DERMABOND® PRINEO® Skin Closure System was shown to provide statistically significant greater skin holding strength than skin staples or subcuticular suture.º2
± Staphylococcus epidermidis, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecium.
º In an ex-vivo study, more load in N was required to create a 3 ±1
1. Su 06TR071 Study Report for in vitro evaluation of microbial barrier properties of DERMABOND ProTape
2. AST-2012-0290: Study to Compare the tissue holding strength of PRINEO™ skin closure